Clinical & Experimental Metastasis

, Volume 34, Issue 5, pp 291–293 | Cite as

PIPAC puts pressure on peritoneal metastases from pancreatic cancer

Commentary

References

  1. 1.
    van Baal JO, Van de Vijver KK, Nieuwland R, van Noorden CJ, van Driel WJ, Sturk A, Kenter GG, Rikkert LG, Lok CA (2017) The histophysiology and pathophysiology of the peritoneum. Tissue Cell 49:95–105. doi:10.1016/j.tice.2016.11.004 CrossRefPubMedGoogle Scholar
  2. 2.
    McMullen JRW, Selleck M, Wall NR, Senthil M (2017) Peritoneal carcinomatosis: limits of diagnosis and the case for liquid biopsy. Oncotarget. doi:10.18632/oncotarget.16480 PubMedPubMedCentralGoogle Scholar
  3. 3.
    Aoyagi T, Terracina KP, Raza A, Takabe K (2014) Current treatment options for colon cancer peritoneal carcinomatosis. World J Gastroenterol 20:12493–12500. doi:10.3748/wjg.v20.i35.12493 CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Lambert LA (2015) Looking up: recent advances in understanding and treating peritoneal carcinomatosis. CA Cancer J Clin 65:284–298. doi:10.3322/caac.21277 CrossRefPubMedGoogle Scholar
  5. 5.
    Newton AD, Bartlett EK, Karakousis GC (2016) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of factors contributing to morbidity and mortality. J Gastrointest Oncol 7:99–111. doi:10.3978/j.issn.2078-6891.2015.100 PubMedPubMedCentralGoogle Scholar
  6. 6.
    Piso P, Arnold D (2011) Multimodal treatment approaches for peritoneal carcinosis in colorectal cancer. Deutsches Arzteblatt Int 108:802–808. doi:10.3238/arztebl.2011.0802 Google Scholar
  7. 7.
    Grass F, Vuagniaux A, Teixeira-Farinha H, Lehmann K, Demartines N, Hubner M (2017) Systematic review of pressurized intraperitoneal aerosol chemotherapy for the treatment of advanced peritoneal carcinomatosis. Br J Surg 104:669–678. doi:10.1002/bjs.10521 CrossRefPubMedGoogle Scholar
  8. 8.
    Girshally R, Demtroder C, Albayrak N, Zieren J, Tempfer C, Reymond MA (2016) Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol 14:253. doi:10.1186/s12957-016-1008-0 CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Blanco A, Giger-Pabst U, Solass W, Zieren J, Reymond MA (2013) Renal and hepatic toxicities after pressurized intraperitoneal aerosol chemotherapy (PIPAC). Ann Surg Oncol 20:2311–2316. doi:10.1245/s10434-012-2840-2 CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Tempfer CB, Winnekendonk G, Solass W, Horvat R, Giger-Pabst U, Zieren J, Rezniczek GA, Reymond MA (2015) Pressurized intraperitoneal aerosol chemotherapy in women with recurrent ovarian cancer: a phase 2 study. Gynecol Oncol 137:223–228. doi:10.1016/j.ygyno.2015.02.009 CrossRefPubMedGoogle Scholar
  11. 11.
    Graversen M, Detlefsen S, Bjerregaard JK, Pfeiffer P, Mortensen MB (2017) Peritoneal carcinomatosis from pancreatic cancer treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC). Clin Exp Metastasis. doi:10.1007/s10585-017-9849-7 PubMedGoogle Scholar
  12. 12.
    Kakchekeeva T, Demtroder C, Herath NI, Griffiths D, Torkington J, Solass W, Dutreix M, Reymond MA (2016) In vivo feasibility of electrostatic precipitation as an adjunct to pressurized intraperitoneal aerosol chemotherapy (ePIPAC). Ann Surg Oncol 23:592–598. doi:10.1245/s10434-016-5108-4 CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2017

Authors and Affiliations

  1. 1.Medical Faculty Mannheim, Centre for Biomedicine and Medical Technology Mannheim (CBTM)University of HeidelbergMannheimGermany
  2. 2.Karlsruhe Institute for Technology (KIT)KarlsruheGermany

Personalised recommendations